1. Home
  2. TRAK vs ABEO Comparison

TRAK vs ABEO Comparison

Compare TRAK & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRAK

ReposiTrak Inc.

HOLD

Current Price

$12.25

Market Cap

245.1M

Sector

Technology

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.32

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRAK
ABEO
Founded
1990
1974
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.1M
281.0M
IPO Year
1998
1980

Fundamental Metrics

Financial Performance
Metric
TRAK
ABEO
Price
$12.25
$5.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$18.20
AVG Volume (30 Days)
96.1K
1.1M
Earning Date
02-11-2026
11-12-2025
Dividend Yield
0.65%
N/A
EPS Growth
19.98
N/A
EPS
0.36
1.29
Revenue
$23,136,391.00
$400,000.00
Revenue This Year
$8.29
N/A
Revenue Next Year
$24.17
$1,589.77
P/E Ratio
$34.36
$4.10
Revenue Growth
11.05
N/A
52 Week Low
$11.98
$3.93
52 Week High
$23.72
$7.54

Technical Indicators

Market Signals
Indicator
TRAK
ABEO
Relative Strength Index (RSI) 30.98 54.91
Support Level $12.91 $4.80
Resistance Level $13.48 $5.55
Average True Range (ATR) 0.53 0.24
MACD -0.05 0.01
Stochastic Oscillator 16.32 66.03

Price Performance

Historical Comparison
TRAK
ABEO

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: